LBRX Stock Analysis: Buy, Sell, or Hold?
LBRX - LB Pharmaceuticals Inc Common Stock
$31.38
-0.43 (-1.35%)
ā¼
5d:
-1.26%
30d:
+31.63%
90d:
+39.28%
BUY
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 15, 2026
15d
Get Alerted When LBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
š” BUY OPPORTUNITY: LBRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
š” BUY OPPORTUNITY: LBRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: LBRX is currently trading at $31.38, which is considered extended relative to its 30-day fair value range of $24.12 to $30.25.
Technical Outlook: Technically, LBRX is in a strong uptrend. Immediate support is located at $26.30, while resistance sits at $33.47.
Market Sentiment: LBRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $44.00 (+40.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LBRX is in a strong uptrend. Immediate support is located at $26.30, while resistance sits at $33.47.
Market Sentiment: LBRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $44.00 (+40.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$24.12 -
$30.25
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.2% below Wall St target ($44.00)
Trading Range Analysis
30-Day Trading Range
$24.12 -
$30.25
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$26.30
Resistance Level
$33.47
Current Trend
Strong Uptrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.01
Wall Street Target
$44.00
(+40.2%)
Share & Embed Analysis
Last updated: April 29, 2026 8:46 AM ET
Data refreshes hourly during market hours. Next update: 9:46 AM
Data refreshes hourly during market hours. Next update: 9:46 AM
š„ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical ā¦ |
STRONG BUY
29 analysts |
$89 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 55 HOLD |
|
BHVN
Biohaven Pharmaceutical ā¦ |
STRONG BUY
16 analysts |
$22 | 53 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$173 | 62 BUY |
|
KRYS
Krystal Biotech Inc |
STRONG BUY
11 analysts |
$315 | 67 BUY |